klaritromütsiini

Klaritromytsin, also known by its brand name Klaricid, is a macrolide antibiotic used to treat various bacterial infections. It is effective against a wide range of bacteria, including those that are resistant to other antibiotics. The drug works by inhibiting bacterial protein synthesis, which is essential for the survival and reproduction of bacteria.

Klaritromytsin is typically administered orally in the form of capsules or tablets. It is well-tolerated by most patients, but like any medication, it can cause side effects. Common side effects include nausea, vomiting, and diarrhea. More serious side effects are rare but can include allergic reactions, liver problems, and changes in blood cell counts.

The use of klaritromytsin is generally reserved for cases where other antibiotics have failed or are not suitable. It is often used to treat respiratory tract infections, skin and soft tissue infections, and sexually transmitted infections. As with any antibiotic, the use of klaritromytsin should be guided by a healthcare professional to ensure appropriate treatment and to monitor for potential side effects.

Klaritromytsin is not recommended for use in pregnant or breastfeeding women unless absolutely necessary, as it may pass into breast milk and could potentially harm a nursing infant. It is also important to complete the full course of treatment as prescribed, even if symptoms improve before the medication is finished, to ensure the infection is fully eradicated.